MFDS — authorised 28 February 2011
- Marketing authorisation holder: ASTRAZENECA PHARMS
- Status: likely_approved
🇰🇷 Daliresp in South Korea
MFDS authorised Daliresp on 28 February 2011
Marketing authorisation
Daliresp in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in South Korea
Frequently asked questions
Is Daliresp approved in South Korea?
Yes. MFDS authorised it on 28 February 2011.
Who is the marketing authorisation holder for Daliresp in South Korea?
ASTRAZENECA PHARMS holds the South Korean marketing authorisation.